Chinese Biotech Firm InnoCare Plans Hong Kong IPO

Beijing InnoCare Pharma Tech Co., which is developing treatments for cancer and autoimmune diseases, is planning a Hong Kong initial public offering, people with knowledge of the matter said. The …
( read original story …)